Abstract Objective Acute pulmonary embolism (APE) is a major cardiovascular disease, the risk stratification is challenging. This study aims to investigate the feasibility of developing a prediction model for risk stratification of APE patients based on radiomics features of the clots. Materials and Methods Computer tomography pulmonary angiography images from 66 APE patients (50% of males, 51.5% of age > 60 years) with different risk levels (33 high-risk and 33 non-high-risk) were analyzed retrospectively. Qanadli and Mastora index was used for evaluating the obstruction degree manually. Radiomics features were extracted from the clots. Independent t-test, least absolute shrinkage selection operator (LASSO) and correlation matrix were used to select the most discriminative features. Support vector machine (SVM), Gaussian Naïve Bayes (GNB), K-Nearest Neighbor (KNN), Decision Tree (DT), Random Forest (RF) and Multi-layer Perceptron-neural net (MLP-NN) were used to build risk stratification models. Mean accuracy and its standard deviation of a 10-fold-cross-validation and the correct rate of these six classifiers were evaluated and compared. Results 1737 radiomics features were extracted from the segmented clots. 16 features, including 5 shape-based features, 8 texture-based features and 3 histogram-based features, were identified as the most discriminative features after eliminating redundant and irrelevant ones. Mean accuracies and their standard deviations showed that MLP-NN had the best performance (0.9042 ± 0.3029), followed by GNB (0.8625 ± 0.3334), SVM (0.8542 ± 0.4070), RF (0.8542 ± 0.3787), KNN (0.8292 ± 0.3038) and DT (0.7667 ± 0.3122), while the GNB model can predict the highest number of the high risk APE patients. MLP-NN yielded the highest correct prediction rate (86.36%), followed by GNB (84.85%), SVM (84.85%), RF (81.82%) and KNN (81.82%), all improved over the clinical scoring systems of Qanadli and Mastora scoring Indices (72.73% and 77.27%). Conclusions The radiomics features combined with MLP-NN can be potentially applied in the clinical risk stratification process to assist the treatment decision for APE patients.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: